乐普医疗
(300003)
| 流通市值：176.52亿 | | | 总市值：206.09亿 |
| 流通股本：15.79亿 | | | 总股本：18.43亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,214,194,092.31 | 1,672,061,164 | 6,482,731,703.55 | 4,938,709,224.18 |
| 营业收入 | 3,214,194,092.31 | 1,672,061,164 | 6,482,731,703.55 | 4,938,709,224.18 |
| 二、营业总成本 | 2,744,393,418.86 | 1,409,787,783.97 | 5,250,530,600.6 | 3,806,841,489.27 |
| 营业成本 | 1,258,141,389.55 | 634,808,816.67 | 2,333,260,819.22 | 1,767,707,481.94 |
| 税金及附加 | 40,920,942.73 | 20,552,615.32 | 86,070,176.78 | 61,366,083.16 |
| 销售费用 | 492,833,491.56 | 246,567,331.93 | 1,169,073,499.05 | 820,741,165.11 |
| 管理费用 | 303,761,967.76 | 129,204,899.17 | 708,801,631.32 | 473,105,528.22 |
| 研发费用 | 476,848,231.31 | 240,543,630.48 | 792,378,182.97 | 594,211,229.49 |
| 财务费用 | 171,887,395.95 | 138,110,490.4 | 160,946,291.26 | 89,710,001.35 |
| 其中:利息费用 | 182,886,263.41 | 147,372,601.3 | 176,640,432.24 | 133,741,215 |
| 其中:利息收入 | 36,372,592.3 | 23,131,859.32 | 71,511,762.48 | 65,202,772.96 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -644,866.85 | -133,143.42 | 1,553,088.27 | -3,815,806.49 |
| 加:投资收益 | 13,340,381.23 | 738,994.03 | 49,445,188.28 | -31,566,578.11 |
| 资产处置收益 | 336,498.9 | -82,367.26 | 4,867,354.39 | -514,648.24 |
| 资产减值损失(新) | -1,143,957.04 | -792,259.96 | -149,398,467.01 | -6,973,231.55 |
| 信用减值损失(新) | -29,944,756.49 | -18,860,779.23 | -64,052,178.08 | -22,922,819.43 |
| 其他收益 | 45,354,677.61 | 21,381,843.22 | 145,454,340.54 | 110,375,129.58 |
| 四、营业利润 | 497,098,650.81 | 264,525,667.41 | 1,220,070,429.34 | 1,176,449,780.67 |
| 加:营业外收入 | 4,264,472.11 | 712,541.71 | 14,437,343.11 | 7,557,394.76 |
| 减:营业外支出 | 16,380,316.17 | 6,449,667.29 | 18,429,646.55 | 24,691,915.83 |
| 五、利润总额 | 484,982,806.75 | 258,788,541.83 | 1,216,078,125.9 | 1,159,315,259.6 |
| 减:所得税费用 | 28,387,905.19 | 35,595,155.2 | 197,074,523.65 | 163,320,989.35 |
| 六、净利润 | 456,594,901.56 | 223,193,386.63 | 1,019,003,602.25 | 995,994,270.25 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 456,594,901.56 | 223,193,386.63 | 1,019,003,602.25 | 995,994,270.25 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 499,475,609.79 | 246,814,412.34 | 962,006,332.53 | 982,053,022.16 |
| 少数股东损益 | -42,880,708.23 | -23,621,025.71 | 56,997,269.72 | 13,941,248.09 |
| 扣除非经常损益后的净利润 | 480,755,800.14 | 241,404,755.77 | 842,496,754.92 | 940,907,198.82 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.27 | 0.13 | 0.52 | 0.53 |
| (二)稀释每股收益 | 0.27 | 0.13 | 0.52 | 0.53 |
| 八、其他综合收益 | 95,706,565.98 | 73,949,750.34 | 351,080,547.85 | 161,148,244.62 |
| 归属于母公司股东的其他综合收益 | 97,653,708.84 | 75,105,312.39 | 355,164,586.09 | 163,604,820.13 |
| 九、综合收益总额 | 552,301,467.54 | 297,143,136.97 | 1,370,084,150.1 | 1,157,142,514.87 |
| 归属于母公司股东的综合收益总额 | 597,129,318.63 | 321,919,724.73 | 1,317,170,918.62 | 1,145,657,842.29 |
| 归属于少数股东的综合收益总额 | -44,827,851.09 | -24,776,587.76 | 52,913,231.48 | 11,484,672.58 |
| 公告日期 | 2026-08-22 | 2026-04-23 | 2026-04-23 | 2025-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |